AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,794,000 | -47.8% | 168,202 | -74.7% | 0.00% | -50.0% |
| Q2 2020 | $11,096,000 | +85.7% | 664,130 | +60.2% | 0.00% | +100.0% |
| Q1 2020 | $5,975,000 | -59.3% | 414,455 | -5.6% | 0.00% | -50.0% |
| Q4 2019 | $14,696,000 | +90.0% | 439,100 | +18.9% | 0.00% | +100.0% |
| Q3 2019 | $7,735,000 | +44.7% | 369,414 | +43.8% | 0.00% | 0.0% |
| Q2 2019 | $5,346,000 | -15.3% | 256,822 | -9.1% | 0.00% | 0.0% |
| Q1 2019 | $6,315,000 | -50.3% | 282,559 | -46.8% | 0.00% | -50.0% |
| Q4 2018 | $12,702,000 | -10.0% | 531,055 | +2.6% | 0.00% | 0.0% |
| Q3 2018 | $14,113,000 | +78.4% | 517,376 | +75.9% | 0.00% | +100.0% |
| Q2 2018 | $7,909,000 | +1.0% | 294,106 | +19.5% | 0.00% | 0.0% |
| Q1 2018 | $7,832,000 | +7.1% | 246,058 | +27.2% | 0.00% | 0.0% |
| Q4 2017 | $7,314,000 | +2.0% | 193,423 | -33.1% | 0.00% | 0.0% |
| Q3 2017 | $7,171,000 | +67.3% | 289,266 | +38.7% | 0.00% | 0.0% |
| Q2 2017 | $4,286,000 | +2.8% | 208,492 | +8.7% | 0.00% | 0.0% |
| Q1 2017 | $4,169,000 | +41.1% | 191,885 | +32.8% | 0.00% | 0.0% |
| Q4 2016 | $2,955,000 | +44.4% | 144,507 | +5.9% | 0.00% | – |
| Q3 2016 | $2,046,000 | +40.8% | 136,447 | +1.6% | 0.00% | – |
| Q2 2016 | $1,453,000 | -26.3% | 134,280 | -7.7% | 0.00% | – |
| Q1 2016 | $1,972,000 | +587.1% | 145,420 | +833.5% | 0.00% | – |
| Q4 2015 | $287,000 | +31.7% | 15,578 | +80.7% | 0.00% | – |
| Q3 2015 | $218,000 | – | 8,619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|